share_log

Together With Siemens Healthineers, Varian Showcases Commitment to Embracing Innovation and Enhancing Outcomes at ESTRO 2024

Together With Siemens Healthineers, Varian Showcases Commitment to Embracing Innovation and Enhancing Outcomes at ESTRO 2024

瓦里安与西门子 Healthineers 一起在 ESTRO 2024 上展示了对拥抱创新和提高成果的承诺
PR Newswire ·  05/02 03:00

PALO ALTO, Calif., May 2, 2024 /PRNewswire/ -- Varian, a Siemens Healthineers company, will showcase its ongoing commitment to embracing innovation and enhancing outcomes for cancer care teams and their patients at this year's 2024 European Society for Radiation Oncology (ESTRO) annual meeting, which will take place from May 3 to 7 in Glasgow, Scotland.

加利福尼亚州帕洛阿尔托,2024年5月2日 /PRNewswire/ — 西门子Healthineers旗下的瓦里安将在今年5月3日至7日在苏格兰格拉斯哥举行的2024年欧洲放射肿瘤学会(ESTRO)年会上展示其对拥抱创新和提高癌症治疗团队及其患者疗效的持续承诺。

With over 24 million new cancer cases expected by 2030, accessible, high-quality cancer treatment is crucial to improving patient outcomes1. Radiotherapy is an integral part of therapeutic treatments for approximately 50% of the patients diagnosed with cancer, yet many countries have inadequate availability of radiotherapy treatment2. Varian is working in collaboration with healthcare providers to change that statistic by creating innovative and integrated solutions to help bring treatment options to those communities who need it most.

到2030年,预计新增癌症病例将超过2400万例,可获得的高质量癌症治疗对于改善患者预后至关重要1。对于大约50%的癌症诊断患者,放射疗法是治疗不可或缺的一部分,但是许多国家的放射疗法治疗供应不足2。瓦里安正在与医疗保健提供商合作,通过创建创新的综合解决方案来改变这一统计数据,为最需要的社区提供治疗选择。

"As part of Siemens Healthineers, Varian is in a unique position to develop cutting-edge products and solutions that bridge the care gap globally," remarked Arthur Kaindl, Head of Varian. "By combining the expertise of the leading imaging and radiotherapy companies, we have the ability to achieve much more than any individual cancer care company by driving connection throughout the entire care continuum."

瓦里安负责人亚瑟·凯恩德尔表示:“作为西门子Healthineers的一部分,瓦里安在开发弥合全球医疗差距的尖端产品和解决方案方面处于独特的地位。”“通过结合领先的成像和放射治疗公司的专业知识,通过推动整个护理过程中的连接,我们有能力取得比任何一家癌症护理公司都要多的成就。”

At the ESTRO meeting, Varian will present a range of solutions that will enhance the care continuum, including:

在 ESTRO 会议上,瓦里安将介绍一系列可增强护理连续性的解决方案,包括:

  • HyperSight imaging solution is now available as an optional feature on Ethos, Halcyon, Edge, and TrueBeam radiotherapy platforms. Delivering a revolution in resolution, HyperSight imaging offers superior image quality, enhanced contrast, and faster image acquisition compared to conventional Varian linear-accelerator-based imaging systems.
  • ARIA CORE, Varian's next-generation oncology management solution, is designed to integrate oncology workflows across cancer care disciplines. ARIA CORE aims to provide care teams with actionable analytics and holistic patient insights for more personalized care and treatment.
  • DirectSetup Notes is a new, advanced tool enabled with syngo CT VB10 on Siemens Healthineers CT simulators SOMATOM go.Sim and SOMATOM go.Open Pro. DirectSetup Notes enables RT staff to document patient setup information during simulation directly on the CT scanner's tablet, allowing RT staff to spend more time with their patients. It then transfers all recorded information directly to ARIA CORE or other oncology information systems for future reference and analysis.
  • MAGNETOM Free.Max RT Edition is the latest addition to the Siemens Healthineers Magnetic Resonance (MR) imaging portfolio for personalized radiation therapy. This new MR system allows users to experience a new level of anatomical detail, increased flexibility, and unconventional affordability due to its lower total cost of ownership than traditional MR systems.
  • The latest version of the IDENTIFY patient motion management system provides users with upgrades designed to optimize performance, increase workflow efficiency, and integrate with treatment delivery, including surface-guided radiotherapy. The IDENTIFY system aims to provide fast, highly precise motion management during the delivery of a wide range of treatments and techniques.
  • HyperSight 成 现已作为可选功能在Ethos、Halcyon、Edge和TrueBeam放射治疗平台上提供。与基于瓦里安线性加速器的传统成像系统相比,HyperSight 成像带来了分辨率的革命,提供了卓越的图像质量、增强的对比度和更快的图像采集速度。
  • 咏叹调核心, 瓦里安的下一代肿瘤学管理解决方案旨在整合跨癌症治疗学科的肿瘤学工作流程。ARIA CORE旨在为护理团队提供切实可行的分析和全面的患者见解,以实现更加个性化的护理和治疗。
  • 直接安装注意事项 是一款新的高级工具,在西门子 Healthineers CT 模拟器 SOMATOM go.sim 和 SOMATOM GO.Open Pro 上支持 syngo CT VB10。DirectSetup Notes使RT工作人员能够直接在CT扫描仪的平板电脑上记录模拟期间的患者设置信息,从而使RT工作人员有更多的时间陪伴患者。然后,它将所有记录的信息直接传输到ARIA CORE或其他肿瘤学信息系统,以供将来参考和分析。
  • MAGNETOM Free.Max RT 版 是西门子Healthineers磁共振(MR)个性化放射治疗成像产品组合的最新成员。由于其总拥有成本低于传统 MR 系统,这种新的 MR 系统使用户能够体验到更高水平的解剖细节、更高的灵活性和非常规的可负担性。
  • 最新版本的 识别患者运动管理 系统为用户提供旨在优化性能、提高工作流程效率并与治疗交付(包括表面引导放射治疗)相集成的升级。IDENTIFY 系统旨在在各种治疗和技术的交付过程中提供快速、高精度的运动管理。

Varian is committed to generating evidence that can help improve patient outcomes and expand access to care. This commitment is evident through its efforts to elevate the standard of care, which will be showcased at ESTRO through numerous oral, panel, customer use cases, and poster presentations. These presentations, which include products such as Ethos and HyperSight imaging, will contribute to the growing body of clinical evidence and data across various treatment domains, further reinforcing Varian's dedication to enhancing patient care.

瓦里安致力于收集有助于改善患者预后和扩大获得医疗服务的证据。这一承诺体现在其为提高护理标准所做的努力中,ESTRO将通过大量口头、小组讨论、客户用例和海报演示来展示这一点。这些演示包括 Ethos 和 HyperSight 成像等产品,将为越来越多的不同治疗领域的临床证据和数据做出贡献,进一步强化瓦里安对加强患者护理的承诺。

VARIAN, HYPERSIGHT, ETHOS, HALCYON, EDGE, TRUEBEAM, ARIA CORE, and IDENTIFY are trademarks of Varian Medical Systems, Inc., pending or registered U.S. Pat. & Tm. Off. MAGNETOM Free.Max, SOMATOM go.Sim, and SOMATOM go.Open Pro are trademarks of Siemens Healthcare GmbH registered U.S. Pat. & Tm. Off.

瓦里安、HYPERSIGHT、ETHOS、HALCYON、EDGE、TRUEBEAM、ARIA CORE 和 IDENTIFY 是瓦里安医疗系统公司的商标,正在申请或注册于美国 Pat. & Tm.关闭。MAGNETOM Free.Max、SOMATOM GO.SIM 和 SOMATOM GO.Open Pro 是西门子医疗保健有限公司在美国注册的商标。关闭。

About Varian
At Varian, a Siemens Healthineers company, we envision a world without fear of cancer. For more than 75 years, Varian has developed, built, and delivered innovative technologies and solutions that help care providers around the globe treat millions of patients each year. Today, as a Siemens Healthineers company, we support every step of the cancer care journey – from screening to survivorship. From advanced imaging and radiation therapy, to comprehensive software and services, to interventional radiology, we are harnessing the power of our perspective while also pursuing clinical research to create a more efficient, and more personalized care pathway. Because, for cancer patients everywhere, their fight is our fight. For more information, visit

关于瓦里安
在西门子健康集团旗下的瓦里安,我们设想一个不用担心癌症的世界。75 年来,瓦里安开发、构建和交付了创新的技术和解决方案,帮助全球医疗服务提供者每年治疗数百万患者。如今,作为西门子Healthineers的一家公司,我们为癌症护理之旅的每一步——从筛查到存活,提供支持。从先进的成像和放射治疗,到全面的软件和服务,再到介入放射学,我们正在利用我们视角的力量,同时进行临床研究,以创建更高效、更个性化的护理途径。因为,对于世界各地的癌症患者来说,他们的斗争就是我们的斗争。欲了解更多信息,请访问

Press Contact
Kristin Corey
Varian Corporate Communications
[email protected]

新闻联系人
克里斯汀·科里
瓦里安企业传播
[电子邮件保护]

1 Cancer Tomorrow | IARC -
2 M Abdel-Wahab, et al. JCO Global Oncol. 2021(7):827-842.

1 明天的癌症 | IARC-
2 M Abdel-Wahab 等JCO Global Oncol. 2021 (7): 827-842.

SOURCE Varian

来源 Varian

声明:本内容仅用作提供资讯及教育之目的,不构成对任何特定投资或投资策略的推荐或认可。 更多信息
    抢沙发